This bold proposal—co-authored by ICAP’s global director, Wafaa El-Sadr—calls for the incoming U.S. administration to create a new entity to marshal the federal government’s resources to manufacture additional vaccine supplies and combine that move with vigorous efforts to boost distribution around the world. The opinion piece was written in collaboration with James Krellenstein, executive director and a co-founder of PrEP4All, an activist think tank dedicated to increasing access to HIV and COVID-19 treatments, and Peter Stanley, a co-founder of PrEP4All and an AIDS activist. 

“Viruses know no borders. Protecting Americans from Covid-19 requires protecting all people from the disease. We will not end the pandemic until everyone, across the world, can receive highly effective vaccines. And the U.S. can help the world more quickly this time. Pepfar was launched seven years after effective H.I.V. treatments were available in rich countries.”

Read the full article in The New York Times

Read the latest ICAP updates on COVID-19 here

Related Items